{"nct_id":"NCT02699099","title":"Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2017-05-10","start_date_type":"ACTUAL","primary_completion_date":"2018-03-14","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}